Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics

Neurology

Volumn 67, Issue 2, 2006, Pages 235-240

  Abbatecola, A M ^a   Rizzo, M R ^a   Barbieri, M ^a   Grella, R ^a   Arciello, A ^a   Laieta, M T ^a   Acampora, R ^b   Passariello, N ^a   Cacciapuoti, F ^a   Paolisso, G ^a,c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Centro Antidiabete Lepanto   (Italy)

^c VI Divisione di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; REPAGLINIDE;

ADULT; AGED; AGING; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN DEGENERATION; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONSTANTS AND COEFFICIENTS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE MODEL; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; ORGAN INJURY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCORING SYSTEM; TISSUE INJURY; TREATMENT OUTCOME; VARIANCE; BLOOD; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

AGED; AGING; BLOOD GLUCOSE; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33747083535     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000224760.22802.e8     Document Type: Article

References (39)

1. Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelium dysfunction and oxidative stress generation. Circulation 2002;106:1211-1218.
2. Ceriello A. Postprandial hyperglycemia and diabetes complications. Is it time to treat? Diabetes 2005;54:1-7.
3. Temelkova-Kurkitschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Post-challenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000;23:1830-1834.
4. Bagg W, Whalley GA, Gamble G, Drury PL, Sharpe N, Braatvedt GD. Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes. Intern Med J 2001;31:322-328.
5. Kalmijn S, Feskens EJM, Launer LJ, Stijnen T, Kromhout D. Glucose intolerance, hyperinsulinemia and cognitive function in a general population of elderly men. Diabetologia 1995;38:1096-1102.
6. Scott RD, Kritz-Silverstein D, Barrett-Connor E, Wiederhlt WC. The association of non-insulin-dependent diabetes mellitus and cognitive function in an older cohort. J Am Geriatr Soc 1998;46:1217-1222.
7. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavourably affected in elderly diabetic subjects: results of the epidemiology of vascular aging study. Diabetes Care 2001;24:366-370.
8. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002;441:1-14.
9. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1, diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
10. Schmidt R, Launer L, Nilsson L, et al. Magnetic resonance imaging of the brain in diabetes. The Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 2004;53:678-692.
11. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
12. Friedewald WT, Levy R, Fredricson DS. Estimation of serum low density lipoprotein without the use of a preparative ultracentrifuge. Clin Chem 1972;18:499-502.
13. Lezak M, Howieson D, Loring D. Neuropsychological assessment. 4th ed. Oxford, UK: Oxford University Press.
14. Reiten R, Wolfson D, eds. The Halstead-Reitan Neuropsychologic Test Battery: theory and clinical interpretation. Neuropsychology Press, 1993.
15. Heaton RK, Nelson LM, Thompson DS, Burks JS, Franklin GM. Neuropsychologic findings in relapsing-remitting and chronic-progressive multiple sclerosis J Consult Clin Psychol 1985;53:103-110.
16. Lamberty GJ, Putnam SH, Chatel DM. Derived Trail Making Test indices. Neuropsychol Behav Neurol 1994;7:230-234.
17. Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996;36:378-384.
18. Grigoletto F, Zappala G, Anderson DW, Lebowitz BD. Norms for the Mini-Mental State Examination in a healthy population. Neurology 1999;53:315-320.
19. American Psychiatric Association Committee on Nomenclature and Semantics. Diagnostic and Statistical Manual of Mental Disorders: DSM IV, 4th ed. Washington, DC: American Psychiatric Press, 1994.
20. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Public Health Nutr 2003;6:407-413.
21. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1: 385-401.
22. Takiuchi S, Rakugi H, Fujii H, et al. Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease. Hypertens Res 2003;12:945-951.
23. Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, de Marco R. Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation 1997;96:1750-1754.
24. Gradman TJ, Laws A, Thompson LW, Reaven GM. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993;41:1305-1312.
25. Naor M, Steingruber HJ, Westhoff K, Schottenfeld-Naor Y, Gries AF. Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control. J Diabetes Complic 1997;11:40-46.
26. Meneilly GS, Cheung E, Tessier D, Yakura C, Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 1993;48:M117-M121.
27. Abbink EJ, van der Wal PS, Sweep CG, Smits P, Tack CJ. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation. Diabetes Metab Res Rev 2004;20:466-471.
28. Baynes C, Elkeles RS, Henderson AD, Richmond W, Johnston DG. The effects of glibenclamide on glucose homeostasis and lipoprotein metabolism in poorly controlled type 2 diabetes. Horm Metab Res 1993;25:96-101.
29. Owens DR, Cozma LS, Luzio SD. Early-phase prandial insulin secretion: its role in the pathogenesis of type 2 diabetes mellitus and its modulation by repaglinide. Diab Nutr Metab 2002;15(suppl 6):19-27.
30. Ratcliff G, Dodge H, Birzescu M, Ganguli M. Tracking cognitive functioning over time: ten-year longitudinal data from a community-based study. Appl Neuropsychol 2003;2:76-88.
31. Kuhl DE, Metter EJ, Riege WH, Hawkins RA. The effects of normal aging on patterns of cerebral glucose utilization. Ann Neurol 1984;15:S133-S137.
32. Pugh K, Lipsitz L. The microvascular frontal-subcortical syndrome of aging. Neurobiol Aging 2002;23:421-431.
33. Yan SD, Chen X, Fu J, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996;382:685-691.
34. Jakobsen J, Nedergaard M, Aarslew-Jensen M, Diemer NH. Regional brain glucose metabolism and blood flow in streptozocin-induced diabetic rats. Diabetes 1990;39:437-440.
35. Du XL, Eldelstein D, Dimmerler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the act site. J Clin Invest 2001;108:1341-1348.
36. Abbatecola AM, Paolisso G, Lamponi M, et al. Insulin resistance and executive dysfunction in older persons. J Am Geriatr Soc 2004;52:1713-1718.
37. Strachan MW. Insulin and cognitive function. Lancet 2003;362:1253.
38. Esposito K, Giugliano D, Nappo F, Marfella R. Campanian Postprandial Hyperglycemia Study Group. Circulation 2004;110:214-219.
39. Morley JE, Perry HM3rd.. The management of diabetes mellitus in older individuals. Drugs 1991;41:548-565.